These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 22234612)

  • 1. Wnt/β-catenin signaling and AXIN1 regulate apoptosis triggered by inhibition of the mutant kinase BRAFV600E in human melanoma.
    Biechele TL; Kulikauskas RM; Toroni RA; Lucero OM; Swift RD; James RG; Robin NC; Dawson DW; Moon RT; Chien AJ
    Sci Signal; 2012 Jan; 5(206):ra3. PubMed ID: 22234612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulating the response to targeted MEK inhibition in melanoma: enhancing apoptosis in NRAS- and BRAF-mutant melanoma cells with Wnt/β-catenin activation.
    Conrad WH; Swift RD; Biechele TL; Kulikauskas RM; Moon RT; Chien AJ
    Cell Cycle; 2012 Oct; 11(20):3724-30. PubMed ID: 22895053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt/β-catenin and MAPK signaling: allies and enemies in different battlefields.
    Guardavaccaro D; Clevers H
    Sci Signal; 2012 Apr; 5(219):pe15. PubMed ID: 22494969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt/β-Catenin Pathway Activation Mediates Adaptive Resistance to BRAF Inhibition in Colorectal Cancer.
    Chen G; Gao C; Gao X; Zhang DH; Kuan SF; Burns TF; Hu J
    Mol Cancer Ther; 2018 Apr; 17(4):806-813. PubMed ID: 29167314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Wnt/β-catenin signaling increases apoptosis in melanoma cells treated with trail.
    Zimmerman ZF; Kulikauskas RM; Bomsztyk K; Moon RT; Chien AJ
    PLoS One; 2013; 8(7):e69593. PubMed ID: 23869245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WNT5A enhances resistance of melanoma cells to targeted BRAF inhibitors.
    Anastas JN; Kulikauskas RM; Tamir T; Rizos H; Long GV; von Euw EM; Yang PT; Chen HW; Haydu L; Toroni RA; Lucero OM; Chien AJ; Moon RT
    J Clin Invest; 2014 Jul; 124(7):2877-90. PubMed ID: 24865425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diminished WNT -> β-catenin -> c-MYC signaling is a barrier for malignant progression of BRAFV600E-induced lung tumors.
    Juan J; Muraguchi T; Iezza G; Sears RC; McMahon M
    Genes Dev; 2014 Mar; 28(6):561-75. PubMed ID: 24589553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-Catenin Attenuation Inhibits Tumor Growth and Promotes Differentiation in a BRAF
    Zou M; BinEssa HA; Al-Malki YH; Al-Yahya S; Al-Alwan M; Al-Jammaz I; Khabar KSA; Almohanna F; Assiri AM; Meyer BF; Alzahrani AS; Al-Mohanna FA; Shi Y
    Mol Cancer Ther; 2021 Sep; 20(9):1603-1613. PubMed ID: 34224366
    [No Abstract]   [Full Text] [Related]  

  • 9. Targeted BRAF inhibition impacts survival in melanoma patients with high levels of Wnt/β-catenin signaling.
    Chien AJ; Haydu LE; Biechele TL; Kulikauskas RM; Rizos H; Kefford RF; Scolyer RA; Moon RT; Long GV
    PLoS One; 2014; 9(4):e94748. PubMed ID: 24733413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of TRIB2 by Wnt/β-catenin activation in BRAF
    Wang N; Wen J; Ren W; Wu Y; Deng C
    Cancer Chemother Pharmacol; 2021 Jul; 88(1):155-164. PubMed ID: 33860836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Nexus Consisting of Beta-Catenin and Stat3 Attenuates BRAF Inhibitor Efficacy and Mediates Acquired Resistance to Vemurafenib.
    Sinnberg T; Makino E; Krueger MA; Velic A; Macek B; Rothbauer U; Groll N; Pötz O; Czemmel S; Niessner H; Meier F; Ikenberg K; Garbe C; Schittek B
    EBioMedicine; 2016 Jun; 8():132-149. PubMed ID: 27428425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting c-Met in melanoma: mechanism of resistance and efficacy of novel combinatorial inhibitor therapy.
    Etnyre D; Stone AL; Fong JT; Jacobs RJ; Uppada SB; Botting GM; Rajanna S; Moravec DN; Shambannagari MR; Crees Z; Girard J; Bertram C; Puri N
    Cancer Biol Ther; 2014 Sep; 15(9):1129-41. PubMed ID: 24914950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axis inhibition protein 1 (Axin1) Deletion-Induced Hepatocarcinogenesis Requires Intact β-Catenin but Not Notch Cascade in Mice.
    Qiao Y; Wang J; Karagoz E; Liang B; Song X; Shang R; Evert K; Xu M; Che L; Evert M; Calvisi DF; Tao J; Wang B; Monga SP; Chen X
    Hepatology; 2019 Dec; 70(6):2003-2017. PubMed ID: 30737831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant activation of Wnt pathway and loss of mismatch repair function in human melanoma.
    Castiglia D; Bernardini S; Alvino E; Pagani E; De Luca N; Falcinelli S; Pacchiarotti A; Bonmassar E; Zambruno G; D'Atri S
    Genes Chromosomes Cancer; 2008 Jul; 47(7):614-24. PubMed ID: 18384130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gliosarcomas lack BRAF
    Schwetye KE; Joseph NM; Al-Kateb H; Rich KM; Schmidt RE; Perry A; Gutmann DH; Dahiya S
    Neuropathology; 2016 Oct; 36(5):448-455. PubMed ID: 26932501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt signaling through inhibition of β-catenin degradation in an intact Axin1 complex.
    Li VS; Ng SS; Boersema PJ; Low TY; Karthaus WR; Gerlach JP; Mohammed S; Heck AJ; Maurice MM; Mahmoudi T; Clevers H
    Cell; 2012 Jun; 149(6):1245-56. PubMed ID: 22682247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to BRAF-targeted Therapy Is Enhanced by Cotargeting VEGFRs or WNT/β-Catenin Signaling in BRAF-mutant Colorectal Cancer Models.
    Tran KB; Kolekar S; Wang Q; Shih JH; Buchanan CM; Deva S; Shepherd PR
    Mol Cancer Ther; 2022 Dec; 21(12):1777-1787. PubMed ID: 36198029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer cells are essential for the ability of BRAF inhibitors to control BRAFV600E-mutant metastatic melanoma.
    Ferrari de Andrade L; Ngiow SF; Stannard K; Rusakiewicz S; Kalimutho M; Khanna KK; Tey SK; Takeda K; Zitvogel L; Martinet L; Smyth MJ
    Cancer Res; 2014 Dec; 74(24):7298-308. PubMed ID: 25351955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MAP3K1 functionally interacts with Axin1 in the canonical Wnt signalling pathway.
    Sue Ng S; Mahmoudi T; Li VSW; Hatzis P; Boersema PJ; Mohammed S; Heck AJ; Clevers H
    Biol Chem; 2010; 391(2-3):171-180. PubMed ID: 20128690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
    Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H
    J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.